GlassScriptPhysician profile
Alyssa Schunk
NPI 1770946790
$695.25
in general payments reported to CMS, 2019-2025
10 companies · $248 in 2025
The $248 reported for 2025 was more than what 80% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.78 · 2022: $66.33 · 2023: $216 · 2024: $153 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $216.23 | 2022-2024 | Auvi-Q |
| Merck Sharp & Dohme LLC | $109.44 | 2019-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Supernus Pharmaceuticals, INC. | $80.90 | 2025 | Qelbree |
| Sanofi Pasteur INC. | $78.85 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $48.82 | 2025 | Neffy |
| Bavarian Nordic A/S | $44.86 | 2025 | Vaxchora, Vivotif |
| Ironshore Pharmaceuticals INC. | $43.18 | 2024 | |
| Glaxosmithkline, LLC. | $27.53 | 2025 | Pediarix, Rotarix, Bexsero |
| Verrica Pharmaceuticals INC. | $23.11 | 2025 | Ycanth |
| Collegium Pharmaceutical, INC. | $22.33 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Schunk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.